Retinal cases & brief reports · 2026
COMBINATION OF METHOTREXATE AND MYCOPHENOLATE MOFETIL FOR REFRACTORY UVEITIS AND SCLERITIS: A Case SERIES.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dutta Majumder Parthopratim, Sen Ahana, Deepak Kene Rakshita, Pradeep Suchitra, Janarthanan Mahesh, Ramanan Athimalaipet V
Аннотация
PURPOSE: This study analyzes the efficacy and safety of combination of methotrexate and mycophenolate mofetil with treatment-resistant uveitis and scleritis.
METHOD: Retrospective chart review.
RESULT: The study included five patients with uveitis and one patient with scleritis who received combination of antimetabolites. The median age of these patients was 19.5 years, and all of them had bilateral involvement. Two patients had juvenile idiopathic arthritis while one patient each had Behçet disease, Eales disease, undifferentiated anterior scleritis, and pars planitis. The median duration of immunosuppressive and/or corticosteroid treatment before switching to combined therapy was 217 (192-1,325) days. Remission of uveitis was achieved in all patients. The median duration of follow-up in these patients was 338.5 (209-901) days. At the end of the follow-up, topical steroids were withdrawn in three eyes, and oral corticosteroids were tapered off completely. All except one patient tolerated the combined treatment.
CONCLUSION: The combination of oral methotrexate and mycophenolate mofetil can be a useful alternative in patients resistant to conventional immunosuppression.
METHOD: Retrospective chart review.
RESULT: The study included five patients with uveitis and one patient with scleritis who received combination of antimetabolites. The median age of these patients was 19.5 years, and all of them had bilateral involvement. Two patients had juvenile idiopathic arthritis while one patient each had Behçet disease, Eales disease, undifferentiated anterior scleritis, and pars planitis. The median duration of immunosuppressive and/or corticosteroid treatment before switching to combined therapy was 217 (192-1,325) days. Remission of uveitis was achieved in all patients. The median duration of follow-up in these patients was 338.5 (209-901) days. At the end of the follow-up, topical steroids were withdrawn in three eyes, and oral corticosteroids were tapered off completely. All except one patient tolerated the combined treatment.
CONCLUSION: The combination of oral methotrexate and mycophenolate mofetil can be a useful alternative in patients resistant to conventional immunosuppression.